Zimmer Biomet Holdings Inc (ZBH)
120.18
-1.05
(-0.87%)
USD |
NYSE |
May 17, 16:00
120.16
-0.02
(-0.02%)
After-Hours: 20:00
Zimmer Biomet Holdings Cash from Operations (Annual): 1.582B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.582B |
December 31, 2022 | 1.285B |
December 31, 2021 | 1.499B |
December 31, 2020 | 1.204B |
December 31, 2019 | 1.586B |
December 31, 2018 | 1.747B |
December 31, 2017 | 1.582B |
December 31, 2016 | 1.632B |
December 31, 2015 | 849.80M |
December 31, 2014 | 1.060B |
December 31, 2013 | 963.10M |
December 31, 2012 | 1.152B |
Date | Value |
---|---|
December 31, 2011 | 1.177B |
December 31, 2010 | 1.194B |
December 31, 2009 | 1.118B |
December 31, 2008 | 1.038B |
December 31, 2007 | 1.084B |
December 31, 2006 | 1.041B |
December 31, 2005 | 878.20M |
December 31, 2004 | 862.20M |
December 31, 2003 | 494.80M |
December 31, 2002 | 220.20M |
December 31, 2001 | 171.80M |
December 31, 2000 | 232.40M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
1.204B
Minimum
2020
1.586B
Maximum
2019
1.431B
Average
1.499B
Median
2021
Cash from Operations (Annual) Benchmarks
Stryker Corp | 3.711B |
Align Technology Inc | 785.78M |
Globus Medical Inc | 243.50M |
Edwards Lifesciences Corp | 895.80M |
ResMed Inc | 693.30M |